
Health.Market March 10, 2021
Crypto or biotech – Both are high risk and high reward investments. Bob Teague, MD layouts out the pros and cons for investors battered
Crypto or biotech – Both are high risk and high reward investments. Bob Teague, MD layouts out the pros and cons for investors battered
A closer look at the funding vehicles driving the VC-backed health tech and biotech markets and the pitfalls for the average investor entering 2022
A look back on the year that was for the healthcare industry and peek ahead for the digital health market in 2022 as we enter
Providing broad access to virtual care seems like an obvious thing to do. And it looks like CMS is at least considering this expansion. The
Organizing healthcare products and services into three categories including biotech complex, information dependent services, and consumer and patient experience and self-care may help track performance
Digital health has been setting records for raising money in the private markets through VC’s and other sources of private investment. The hype is enormous
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much
It was a strange week. The market was right about the numbers. When the predicted happened, not much happened at the headline level but
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.